| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8654b3f7649d7b5ff5036530a378d2a8 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C337-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F1-08 |
| filingDate |
2007-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_667dd05697965faa9a012d00487af00b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78d49c00b7faef0614888ac1982b6cac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0bb38cd4180fff2b7c502a38d8cafa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dcfcd13727b2fbb659b5b923c4c6d0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1bbb3a81805d7191308442b599686e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a737f89ed9df7976f7c58a97fa88456 |
| publicationDate |
2008-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MD-3655-F1 |
| titleOfInvention |
Inhibitor of human myeloid leukemia based on bis (2-hydroxy-8-phenyl-tricyclo / 7.3.1.0.2,7 / tridecan-13-on-thiosemicarbazonate) copper |
| abstract |
The invention relates to chemistry, namely to the coordinating compound synthesis in the class of transition metal thiosemicarbazates and may be applied to medicine for the prophylaxis and treatment of myeloid leukemia. The essence of the invention is that copper (2-hydroxy-8-phenyl-tricyclo / 7.3.1.0.2,7 / tridecan-13-on-thiosemicarbazonate) is proposed as a human myeloid leukemia inhibitor: |
| priorityDate |
2007-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |